Skip to content
FrontierPicks

Covered

CLMT · Calumet

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $40.20

Note written ·

Price against the kill line

14.7% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

CLMTCalumet
$40.20
$34.30
14.7%well clear

Three months against the kill line

CLMT daily closes from 17 August 2026 to 13 November 2026, last $34.30, against its kill line: a daily close above $40.20. 17 August 2026: $48.3518 August 2026: $50.8119 August 2026: $49.1920 August 2026: $48.2921 August 2026: $49.0124 August 2026: $47.3225 August 2026: $47.0326 August 2026: $47.7927 August 2026: $45.7728 August 2026: $47.7531 August 2026: $49.731 September 2026: $51.522 September 2026: $53.073 September 2026: $53.504 September 2026: $53.138 September 2026: $53.919 September 2026: $55.6910 September 2026: $56.4411 September 2026: $56.8014 September 2026: $56.5515 September 2026: $57.5516 September 2026: $58.0117 September 2026: $59.0518 September 2026: $59.0021 September 2026: $58.1222 September 2026: $56.4223 September 2026: $54.3824 September 2026: $53.8525 September 2026: $53.6528 September 2026: $52.6129 September 2026: $53.2330 September 2026: $52.381 October 2026: $53.722 October 2026: $55.285 October 2026: $56.036 October 2026: $56.217 October 2026: $56.298 October 2026: $57.759 October 2026: $56.4212 October 2026: $57.1713 October 2026: $58.5914 October 2026: $57.5315 October 2026: $58.2416 October 2026: $57.7519 October 2026: $55.5420 October 2026: $56.0521 October 2026: $52.5922 October 2026: $49.3223 October 2026: $49.3126 October 2026: $52.1727 October 2026: $49.8928 October 2026: $49.8929 October 2026: $48.5330 October 2026: $49.652 November 2026: $46.733 November 2026: $47.334 November 2026: $43.605 November 2026: $43.356 November 2026: $39.649 November 2026: $36.0610 November 2026: $34.9111 November 2026: $35.8912 November 2026: $36.4513 November 2026: $34.30

Daily closes, to . Red: the kill line, a daily close above $40.20, on record since 11 November 2026. The shares are down 29.1% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $40.20, which would put the shares back over the 200-day moving average and the 6 November 2026 post-report close and show them leading the S&P 500; so would Calumet announcing the 80 million gallon SAF run-rate reached before 31 December 2026.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Energy

Quarter to 30 September 2026, filed 6 November 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
1,683
Revenue, change on a year (%)
+56.1
Gross margin (%)
32.3
Operating margin (%)
27.0
Free cash flow, four quarters ($M)
265
Net cash, cash less debt ($M)
−1,947
Enterprise value to sales (×)
1.0
Enterprise value to operating income (×)
27.9
All filed numbers

What Calumet reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 1,683 +56.1 32.3 27.0
first filed 1,445 +40.8 1.3 −2.8
first filed 1,030 +3.6 −8.5 −16.6
first filed 1,039 +9.4 −0.3 −6.2
first filed 1,078 −2.0 34.7 30.0
first filed 1,027 −9.4 −4.2 −9.8
Income Quarter to 30 September 2026, filed 6 November 2026
Pre-tax income ($M) 245
Net income ($M) four quarters: −194 256
Diluted shares, change on a year (%) against the quarter to 30 September 2025 +1.3
Cash flow Four quarters to 30 September 2026, filed 6 November 2026
Operating cash flow ($M) 341
Capital spending ($M) 76.0
Free cash flow ($M) 265
Balance sheet At 30 September 2026, filed 6 November 2026
Cash and short-term investments ($M) 225
Debt ($M) 2,172
Net cash, cash less debt ($M) −1,947
Deferred revenue ($M) Not reported
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 466
Inventory ($M) 473
Shareholders' equity ($M) including non-controlling interests −871
Valuation At the 13 November 2026 close, filed figures to 6 November 2026
Market value ($M) 3,022
Enterprise value, market value plus net debt ($M) 4,968
Enterprise value to sales (×) 1.0
Enterprise value to operating income (×) 27.9
Price to earnings (×) Not meaningful
Price to book value (×) Not meaningful
Free-cash-flow yield (%) 8.8

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 4.9% of shares outstanding sold short, 3.1 days of average trading to cover, +21.3% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $0and 1 trade without a stated price
12 monthsfrom $0 $20.7Mand 3 trades without a stated price

The thesis

Calumet's shares are more likely to lag the S&P 500 over the next three months. A record third quarter has not stopped the selling. The case now rests on two things management has promised but not yet delivered: Montana Renewables back online in the last week of November 2026 after its expansion tie-in, and a sustainable aviation fuel (SAF) run-rate of 80 million gallons a year by year-end 2026.

The shares closed at $35.89 on 11 November 2026, down from $43.35 on 5 November 2026, the day before the report. Adjusted daily closes show a 26.4% fall over three months. The last close is 40.1% below the intraday 52-week high of $59.87 set on 21 September 2026. The rating is Low because the operating results are strong while the price keeps falling, and the next proof points come only after the plant restarts.

The market is pricing the third quarter as a peak. On 6 November 2026, MarketBeat reported an 8.8% intraday fall to $39.55 on the same day Calumet reported $2.91 a share against a $1.59 consensus cited by Benzinga. Calumet trades as a legacy specialty refiner turning existing equipment into renewable-fuel capacity. Policy credits, compliance costs and the timing of the Montana project move the shares as much as quarterly profit does.

Bullish and bearish views on Calumet, Inc.

The bull case on Calumet, Inc. (CLMT), in brief: the third quarter beat by a wide margin. The bear case: the selling has continued after the report.

Bull case

  • The third quarter beat by a wide margin. Calumet reported net income of $273.3 million, or $2.91 per share, on 6 November 2026. Sales were $1.6829 billion, and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) with tax attributes was $347.2 million, up from $92.5 million a year earlier.
  • Specialty margins nearly doubled. Specialty Products & Solutions adjusted EBITDA was $248.1 million, up from $80.2 million a year earlier, per the 6 November 2026 release. On the call that day, management put the specialty materials margin above $108 a barrel, up from $62.
  • Montana Renewables set a record. The subsidiary earned $80.4 million of adjusted EBITDA with tax attributes in the third quarter, or $1.86 a gallon, per the 6 November 2026 release.
  • The expansion tie-in started on schedule. Management said on 6 November 2026 that the tie-in began that week as planned, with the plant expected back online in the last week of November. The SAF targets were restated: 80 million gallons a year by year-end 2026 and 200 million in 2028.
  • Calumet now owns all of Montana Renewables' common equity. Under the 5 November 2026 agreement, Warburg Pincus exchanged its 13.17% stake for warrants on up to 8%, exercisable only above a $750 million common equity value. Calumet Montana Refining also leases expansion equipment to the subsidiary for about $30 million of annual income, subject to adjustments.
  • Debt is coming down. Calumet has retired about $265 million of debt since July, including $150 million of 2028 notes redeemed on 25 October 2026. Management put net leverage for the restricted group, which excludes Montana Renewables, at about 2.3 times on 6 November 2026.

Bear case

  • The selling has continued after the report. Adjusted daily closes show $39.64 on 6 November 2026, $36.06 on 9 November 2026, $34.91 on 10 November 2026 and $35.89 on 11 November 2026. MarketBeat noted on 6 November 2026 that Zacks Research cut the stock to hold from strong buy.
  • The fourth quarter carries a plant outage. Montana Renewables went offline for the tie-in in the week of 6 November 2026 and is not expected back until the last week of November, per the earnings call. The fourth-quarter report will include that downtime.
  • Year-to-date results are still negative. The 6 November 2026 release shows a $139.6 million net loss for the first nine months. Third-quarter derivative losses were $153.2 million, against $1.5 million a year earlier.
  • Compliance obligations have grown. The current obligation for Renewable Identification Numbers (RINs) rose to $303.4 million at 30 September 2026, from $169.3 million at year-end 2025, per the third-quarter release.
  • The new Warburg terms cost more. Under the 5 November 2026 revision, Warburg Pincus's preferred units rise to about $395 million from about $346 million, and the preferred return rises to 11.5%. Management said on 6 November 2026 that the return will be paid in kind, added to the balance, until the project is complete.
  • The balance sheet shows a deficit. Stockholders' equity was a deficit of $870.7 million at 30 September 2026, with $225.2 million of cash, per the third-quarter release.
  • A director sold in the open market. SEC Form 4 filings show director Stephen Mawer exercised 61,387 options and sold 24,555 shares on 25 September 2026. Filings by the chief executive, the chief financial officer and two other officers on 25 September 2026 and 19 October 2026 show option exercises with shares withheld for tax.

Price setup

The close of $35.89 on 11 November 2026 is below the 200-day moving average of $39.33 and far below the 50-day moving average of $52.58, both as of that close. The shares broke under the 200-day average in the 9 November 2026 session and have not closed back above it. The lowest close since the report was $34.91 on 10 November 2026.

The longer range is still wide. The 52-week closing low is $18.22 from 20 November 2025, and the intraday 52-week high is $59.87 from 21 September 2026. The 3-month reference close was $48.79 on 13 August 2026.

Analyst views are split. MarketBeat's count on 6 November 2026 showed two buys, four holds and one sell, with a $54.75 average target. The last close sits well below that average.

Catalysts ahead

  • ~30 November 2026 (est.): Montana Renewables restart after the MaxSAF tie-in. Management expects the plant back online in the last week of November; a restart in that window keeps the year-end run-rate goal possible, while a slip into 2027 breaks the timetable.
  • ~31 December 2026 (est.): Year-end SAF run-rate checkpoint. Management targets an annual SAF run-rate of 80 million gallons by this date; reaching it would show the expansion working, and falling short breaks the timetable.
  • ~26 February 2027 (est.): Fourth-quarter 2026 results. First report after the tie-in; shows the outage's cost, post-expansion Montana Renewables volumes, remaining capital against the $137 million plan and whether specialty margins held.

What would change the view

A daily close above $40.20, which would put the shares back over the 200-day moving average and the 6 November 2026 post-report close and show them leading the S&P 500; so would Calumet announcing the 80 million gallon SAF run-rate reached before 31 December 2026.

What it trades with

The shares follow renewable-fuel policy: 45Z clean-fuel credits, RIN prices and decisions on small-refinery exemptions. They also follow specialty refining margins, which the company tracks per barrel against crude costs. Diesel and jet fuel cracks feed both segments. Calumet has partly decoupled from crude benchmarks because policy credits drive Montana Renewables' earnings. The Warburg Pincus warrant ties some upside to any future sale or listing of the subsidiary above a $750 million common equity value.

The evidence, claim by claim (8)
  1. Third-quarter 2026 net income was $273.3 million, or $2.91 per share, on sales of $1.6829 billion; adjusted EBITDA with tax attributes was $347.2 million, up from $92.5 million. Calumet Q3 2026 results release · as of
  2. Montana Renewables earned a record $80.4 million of adjusted EBITDA with tax attributes, $1.86 per gallon; Specialty Products & Solutions adjusted EBITDA was $248.1 million, up from $80.2 million. Calumet Q3 2026 results release · as of
  3. The tie-in began the week of the call; management expects Montana Renewables back online in the last week of November and targets an 80 million gallon annual SAF run-rate by year-end 2026. Calumet Q3 2026 earnings call · as of
  4. Warburg Pincus swaps its 13.17% Montana Renewables stake for warrants on up to 8% above a $750 million equity value; its preferred units rise to about $395 million at an 11.5% return. Calumet release, 'CMR Asset Lease Details and Revised Agreement with Warburg Pincus' · as of
  5. The current RIN obligation rose to $303.4 million from $169.3 million at year-end 2025; nine-month 2026 results show a $139.6 million net loss. Calumet Q3 2026 results release · as of
  6. About $265 million of debt was retired since July, including $150 million of 2028 notes on 25 October 2026; management put restricted-group net leverage at about 2.3 times. Calumet Q3 2026 results release and earnings call · as of
  7. Shares fell 8.8% intraday to $39.55 on volume about 36% above average; consensus is Hold (2 buy, 4 hold, 1 sell) with a $54.75 average target. MarketBeat, 'Calumet (NASDAQ:CLMT) Shares Down 8.8%' · as of
  8. Director Stephen Mawer exercised 61,387 options and sold 24,555 shares in the open market on 25 September 2026. SEC Form 4 filed 28 September 2026 · as of

Sources

Related · shared themes

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X